Supplementary Table 3 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
Year: 2025
Type: supplementary-materials
Abstract: The value of eRIS in all cancer samples.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4410340301
